Ovitrelle 250 mcg/0.5 ml

Ovitrelle 250 mcg is a solution for injection containing Choriogonadotropin alfa, a recombinant form of Human Chorionic Gonadotropin (hCG).It is supplied in a pre-filled syringe containing 0.5 ml of solution for subcutaneous use.
Ovitrelle is widely used in fertility treatments to trigger ovulation and support reproductive procedures such as IVF, IUI, and timed intercourse.

Manufacturer : Merck

Composition
Choriogonadotropin alfa: 250 mcg
Solution: 0.5 ml ready-to-inject liquid

Recombinant hCG (Choriogonadotropin alfa)

Strength: 250 mcg / 0.5 ml
Form: Pre-filled syringe
Route: Subcutaneous injection
High purity recombinant formulation

Ovitrelle is used for:
Triggering final follicular maturation
Supporting ovulation in women undergoing fertility treatment
Supporting luteal phase in assisted reproductive technologies (ART)